We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.41B
AUM Growth
+$131M
(+3.1%)
Cap. Flow
-$472M
Cap. Flow
% of AUM
-10.71%
Top 10 Holdings %
Top 10 Hldgs %
31.99%
Holding
983
New
316
Increased
242
Reduced
174
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$145M |
| 2 |
Amgen
AMGN
|
+$84.8M |
| 3 |
Perrigo
PRGO
|
+$60.8M |
| 4 |
Tenet Healthcare
THC
|
+$53.5M |
| 5 |
Cardinal Health
CAH
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$132M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$80.9M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$65M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$65M |
| 5 |
Gilead Sciences
GILD
|
+$51.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.02% |
| 2 | Consumer Staples | 4.24% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Industrials | 3.96% |
| 5 | Utilities | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Andersons Inc
ANDE
$2.41B
| $205K | ﹤0.01% |
+4,395
| New | +$185K |
|
|
AMRN
702
Amarin Corp
AMRN
$299M
| $203K | ﹤0.01% |
+1,606
| New | +$192K |
|
703
Cognex
CGNX
$10.9B
| $203K | ﹤0.01% |
+12,970
| New | +$181K |
|
704
First Bancorp
FBP
$4.42B
| $203K | ﹤0.01% |
+35,810
| New | +$253K |
|
705
Gentex
GNTX
$4.97B
| $203K | ﹤0.01% |
+15,846
| New | +$188K |
|
|
PARA
706
DELISTED
Paramount Global Class B
PARA
| $202K | ﹤0.01% |
+3,658
| New | +$195K |
|
|
DELL
707
DELISTED
DELL INC
DELL
| $202K | ﹤0.01% |
14,646
-363,444
| -96% | -$4.92M |
|
708
Generac Holdings
GNRC
$11.6B
| $201K | ﹤0.01% |
+4,717
| New | +$196K |
|
709
Pultegroup
PHM
$24.1B
| $200K | ﹤0.01% |
+12,141
| New | +$207K |
|
710
Thor Industries
THO
$3.9B
| $200K | ﹤0.01% |
+3,440
| New | +$182K |
|
711
Xerox
XRX
$387M
| $194K | ﹤0.01% |
+7,161
| New | +$188K |
|
|
JNS
712
DELISTED
Janus Capital Group Inc
JNS
| $188K | ﹤0.01% |
+22,113
| New | +$198K |
|
713
Sibanye-Stillwater
SBSW
$6.26B
| $166K | ﹤0.01% |
+33,703
| New | +$123K |
|
714
RPC Inc
RES
$1.24B
| $161K | ﹤0.01% |
+10,409
| New | +$152K |
|
715
Coeur Mining
CDE
$15.4B
| $158K | ﹤0.01% |
+13,098
| New | +$179K |
|
|
HIMX
716
Himax Technologies
HIMX
$2.19B
| $150K | ﹤0.01% |
+15,007
| New | +$107K |
|
717
Prospect Capital
PSEC
$1.07B
| $147K | ﹤0.01% |
+13,111
| New | +$146K |
|
|
ANR
718
DELISTED
Alpha Natural Resources Inc
ANR
| $133K | ﹤0.01% |
+22,275
| New | +$131K |
|
|
ZNGA
719
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $125K | ﹤0.01% |
33,980
-93,948
| -73% | -$297K |
|
720
Alcoa
AA
$11.9B
| $124K | ﹤0.01% |
6,367
-12,969
| -67% | -$251K |
|
721
LXP Industrial Trust
LXP
$3.57B
| $117K | ﹤0.01% |
+2,077
| New | +$125K |
|
722
Marvell Technology
MRVL
$168B
| $117K | ﹤0.01% |
+10,172
| New | +$126K |
|
723
First Horizon
FHN
$12.2B
| $116K | ﹤0.01% |
+10,556
| New | +$124K |
|
724
MGIC Investment
MTG
$6.16B
| $116K | ﹤0.01% |
16,000
+1,314
| +9% | +$9.33K |
|
|
GTAT
725
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
| $116K | ﹤0.01% |
+13,618
| New | +$81.2K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2013 Portfolio in Review
As of Q3 2013, Visium Asset Management held 983 positions worth $4.41B, up 3.1% from $4.28B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management withdrew a net $472M in Q3 2013, closing 237 positions and reducing 174 holdings. Its most notable exit was Bausch Health, an estimated $132M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Visium Asset Management opened a new position in Brookdale Senior Living worth $37.5M.
- Visium Asset Management's largest Q3 2013 buy was Brookdale Senior Living: 1,426,060 shares worth $37.5M.
- Visium Asset Management added most to Allergan Inc in Q3 2013, an estimated $145M increase.
- Visium Asset Management's biggest Q3 2013 reduction was Endo International plc, cutting an estimated $80.9M.
- Visium Asset Management fully exited Bausch Health in Q3 2013, selling an estimated $132M.
- Visium Asset Management's ten largest holdings make up 32% of its $4.41B portfolio in Q3 2013.
- Visium Asset Management opened 316 new positions and closed 237 in Q3 2013.
- Visium Asset Management's portfolio value rose 3.1% quarter-over-quarter to $4.41B.
Based on Visium Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.